BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 5 hits Enz. Inhib. hit(s) with Target = 'Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform' and Ligand = 'BDBM203396'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM203396
PNG
(US9539260, B52 | US9539260, B53 | US9763952, Examp...)
Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOC3)cc12
Show InChI InChI=1S/C24H29N3O6S/c1-16-11-18(13-25-23(16)34(2,29)30)27-8-10-32-22-4-3-19(12-21(22)27)33-20-5-7-26(14-20)24(28)17-6-9-31-15-17/h3-4,11-13,17,20H,5-10,14-15H2,1-2H3/t17?,20-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<3n/an/an/an/an/a25



NOVARTIS AG

US Patent


Assay Description
Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1...


US Patent US9539260 (2017)


BindingDB Entry DOI: 10.7270/Q2W37TH1
More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM203396
PNG
(US9539260, B52 | US9539260, B53 | US9763952, Examp...)
Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOC3)cc12
Show InChI InChI=1S/C24H29N3O6S/c1-16-11-18(13-25-23(16)34(2,29)30)27-8-10-32-22-4-3-19(12-21(22)27)33-20-5-7-26(14-20)24(28)17-6-9-31-15-17/h3-4,11-13,17,20H,5-10,14-15H2,1-2H3/t17?,20-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 3n/an/an/an/an/an/a



NOVARTIS AG

US Patent




US Patent US9763952 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM203396
PNG
(US9539260, B52 | US9539260, B53 | US9763952, Examp...)
Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOC3)cc12
Show InChI InChI=1S/C24H29N3O6S/c1-16-11-18(13-25-23(16)34(2,29)30)27-8-10-32-22-4-3-19(12-21(22)27)33-20-5-7-26(14-20)24(28)17-6-9-31-15-17/h3-4,11-13,17,20H,5-10,14-15H2,1-2H3/t17?,20-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<3n/an/an/an/an/an/a



NOVARTIS AG

US Patent




US Patent US9763952 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM203396
PNG
(US9539260, B52 | US9539260, B53 | US9763952, Examp...)
Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOC3)cc12
Show InChI InChI=1S/C24H29N3O6S/c1-16-11-18(13-25-23(16)34(2,29)30)27-8-10-32-22-4-3-19(12-21(22)27)33-20-5-7-26(14-20)24(28)17-6-9-31-15-17/h3-4,11-13,17,20H,5-10,14-15H2,1-2H3/t17?,20-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.5n/an/an/an/an/an/a



NOVARTIS AG

US Patent




US Patent US9763952 (2017)

More data for this
Ligand-Target Pair
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform


(Homo sapiens (Human))
BDBM203396
PNG
(US9539260, B52 | US9539260, B53 | US9763952, Examp...)
Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3CCOC3)cc12
Show InChI InChI=1S/C24H29N3O6S/c1-16-11-18(13-25-23(16)34(2,29)30)27-8-10-32-22-4-3-19(12-21(22)27)33-20-5-7-26(14-20)24(28)17-6-9-31-15-17/h3-4,11-13,17,20H,5-10,14-15H2,1-2H3/t17?,20-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 4.5n/an/an/an/an/a25



NOVARTIS AG

US Patent


Assay Description
Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1...


US Patent US9539260 (2017)


BindingDB Entry DOI: 10.7270/Q2W37TH1
More data for this
Ligand-Target Pair